Close

Analyst Ratings for 10X Genomics (TXG) [Neutrals]

TXG Rating Summary

TXG Price Target Summary

* Over Last 12-Mos
  |   Expand Research on TXG
Overall Rating: BUY   Rating Trend: Down   Avg. $ Target: $54.17 (+83.4%) * Over Last 12-Mos
Rating Score: 7.5 / 10   Percentile Rank: 80%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
12/12/2023 BofA Securities Derik de Bruin Upgrade Neutral
(Underperform)
54.00
(36.00)
48.14
(29.53)
-38.66% Details
2/2/2023 UBS
» Updated 2/21/2024
John Sourbeer New Coverage Neutral
(N/A)
52.00
(44.00)
47.59
(29.53)
-37.95% Details